| Value | ₹3.01 Cr |
|---|
BSE filing, NSE: ACCEL. Summary written from the filing by ALFA Finder's alert engine.
ACCEL Ltd: key numbers
- Share price
- ₹10.80
- Market cap
- ₹62.18 Cr
- Revenue (annual)
- ₹164.3 Cr
- Net profit (annual)
- ₹5.33 Cr
- P/E (TTM)
- 16.3×Sector 23.2×
- Promoter holding
- 71.44%+0.04% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ACCEL Ltd
All →ACCEL Q2 FY27 Results: Net Profit ₹1 Cr, Up 25.0% YoY
ACCEL Ltd reported revenue from operations of ₹58.1 Cr (+33.3% YoY) and net profit of ₹1 Cr (+25.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1 Cr · +25.0% YoY
ACCEL Board Meeting Date
Accel will hold a board meeting on 13 November 2026 to approve Q2 and half-year unaudited results. The trading window remains closed until 17 November 2026.
ACCEL Other Announcement
Accel Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This routine disclosure details the company's shareholding structure as per regulatory requirements.
ACCEL Annual General Meeting
Accel Limited conducted its 40th Annual General Meeting on September 29, 2026. Members transacted all business items as per the notice provided in the meeting.
ACCEL Promoter Buying
Promoter N R Panicker acquired 10,658 shares of Accel Limited via the open market. The acquisition marginally increases the promoter's stake in the company.
- Promoter stake change
- +0.01%
ACCEL Promoter Buying: ₹0.01 Cr
Promoter and Director N R Panicker acquired 10,658 equity shares of Accel Ltd via market purchase. The transaction is valued at approximately ₹0.01 Crore.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.01%
Other acquisition announcements
All →Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.
Advent Hotels International Acquisition Worth ₹5.38 Cr
Advent Hotels acquired 50% control of Advent Convention and Hotels International Pvt Ltd for Rs.5.38 Crore cash. The target will develop a Mumbai commercial project.
- Value
- ₹5.38 Cr
- Execution
- Indicative completion date stated as 17-11-2026
Phoenix Mills Acquisition Worth ₹373.9 Cr
Phoenix Mills' stake in subsidiary ISMDPL rose to 71.23% after ISMDPL bought back CPP Investments' shares. Consideration was Rs.373.88 Crore, paid on 18 November 2026.
- Value
- ₹373.9 Cr
AYM Syntex Acquisition
NCLT Mumbai sanctioned the amalgamation of Mandawewala Enterprises into AYM Syntex, effective on sanction. The formal order is awaited and will be disclosed when received.
Prestige Estates Projects Acquisition Worth ₹2.69 Cr
Prestige's subsidiary acquired 50% of Advent Convention for ₹2.69 Crore. The target holds 21,978 sq. m land in Mumbai for a ₹4,500 Crore commercial project.
- Value
- ₹2.69 Cr
- leasable area
- 1500000 sq. ft.
Insecticides (India) Acquisition Worth ₹3.54 Cr
Insecticides (India) invested Rs. 3.54 Crore for a 26% stake in FP Alpha Private Limited. The acquisition targets wind and solar captive power capacity in Gujarat.
- Value
- ₹3.54 Cr